118 related articles for article (PubMed ID: 2122146)
1. Inhibition of HIV replication by naphthalenemonosulfonic acid derivatives and a bis naphthalenedisulfonic acid compound.
Mohan P; Singh R; Wepsiec J; Gonzalez I; Sun DK; Sarin PS
Life Sci; 1990; 47(12):993-9. PubMed ID: 2122146
[TBL] [Abstract][Full Text] [Related]
2. Novel naphthalenedisulfonic acid anti-HIV-1 agents. Synthesis and activity against reverse transcriptase, virus replication and syncytia formation.
Mohan P; Singh R; Baba M
Drug Des Discov; 1991 Nov; 8(1):69-82. PubMed ID: 1725723
[TBL] [Abstract][Full Text] [Related]
3. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
Dis Markers; 1990; 8(3):162-3. PubMed ID: 2125537
[No Abstract] [Full Text] [Related]
4. MAP 30: a new inhibitor of HIV-1 infection and replication.
Lee-Huang S; Huang PL; Nara PL; Chen HC; Kung HF; Huang P; Huang HI; Huang PL
FEBS Lett; 1990 Oct; 272(1-2):12-8. PubMed ID: 1699801
[TBL] [Abstract][Full Text] [Related]
5. Potential anti-AIDS agents. Synthesis and antiviral activity of naphthalenesulfonic acid derivatives against HIV-1 and HIV-2.
Mohan P; Singh R; Baba M
J Med Chem; 1991 Jan; 34(1):212-7. PubMed ID: 1704064
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies with symmetric naphthalenesulfonic acid derivatives. Synthesis and influence of spacer and naphthalenesulfonic acid moiety on anti-HIV-1 activity.
Mohan P; Wong MF; Verma S; Huang PP; Wickramasinghe A; Baba M
J Med Chem; 1993 Jul; 36(14):1996-2003. PubMed ID: 8336338
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of human cytomegalovirus replication by naphthalenedisulfonic acid derivatives.
Baba M; Konno K; Shigeta S; Wickramasinghe A; Mohan P
Antiviral Res; 1993 Mar; 20(3):223-33. PubMed ID: 8385895
[TBL] [Abstract][Full Text] [Related]
8. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.
Ota A; Liu X; Fujio H; Sakato N; Ueda S
Hybridoma; 1998 Feb; 17(1):73-5. PubMed ID: 9523241
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia.
Kristiansen JE; Hansen JB
Int J Antimicrob Agents; 2000 Apr; 14(3):209-13. PubMed ID: 10773489
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of infected cell appearance as a determinant of number of human immunodeficiency virus-1 infectious units.
Cory JM; Ohlsson-Wilhelm BM; Steck ME; Smithgall MD; Rozday V; Eyster ME; Rapp F
AIDS Res Hum Retroviruses; 1989 Feb; 5(1):97-106. PubMed ID: 2497763
[TBL] [Abstract][Full Text] [Related]
11. The effect of alcohol on HIV infection in vitro.
Saravolatz LD; Cerra RF; Pohlod DJ; Smereck S
Prog Clin Biol Res; 1990; 325():267-71. PubMed ID: 2105508
[No Abstract] [Full Text] [Related]
12. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl sulfoxide inhibits human immunodeficiency virus production in vitro.
Viza D; Aranda-Anzaldo A; Zompetti C; Vich JM
Intervirology; 1991; 32(1):59-64. PubMed ID: 1707866
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of HIV protease inhibitors. Variations of the carboxy terminus of the HIV protease inhibitor L-682,679.
deSolms SJ; Giuliani EA; Guare JP; Vacca JP; Sanders WM; Graham SL; Wiggins JM; Darke PL; Sigal IS; Zugay JA
J Med Chem; 1991 Sep; 34(9):2852-7. PubMed ID: 1910089
[TBL] [Abstract][Full Text] [Related]
15. Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6.
Carrigan DR; Knox KK; Tapper MA
J Infect Dis; 1990 Oct; 162(4):844-51. PubMed ID: 2169498
[TBL] [Abstract][Full Text] [Related]
16. [Expression and characterization of HIV-1 Gag p17-p24 protein].
Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
[TBL] [Abstract][Full Text] [Related]
17. CD4-modified synthetic peptides containing phenylalanine inhibit HIV-1 infection in vitro.
Lasarte JJ; Sarobe P; Golvano J; Prieto I; Civeira MP; Gullón A; Sarin PS; Prieto J; Borrás-Cuesta F
J Acquir Immune Defic Syndr (1988); 1994 Feb; 7(2):129-34. PubMed ID: 8301524
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV-1 and HIV-2 activity of naphthalenedisulfonic acid derivatives. Inhibition of cytopathogenesis, giant cell formation, and reverse transcriptase activity.
Mohan P; Singh R; Baba M
Biochem Pharmacol; 1991 Feb; 41(4):642-6. PubMed ID: 1705124
[No Abstract] [Full Text] [Related]
19. In vitro assays show a dissociation of reverse transcriptase activity and core antigen (p24) production in two HIV-1 isolates from a patient receiving long-term treatment with zidovudine (ZDV).
Masquelier B; Combeau T; Poveda JD; Delord B; Pellegrin JL; Sallafranque-Andreola ML; Tarrago-Litvak L; Fleury HJ
J Acquir Immune Defic Syndr (1988); 1991; 4(5):499-505. PubMed ID: 1707962
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application.
Howard OM; Oppenheim JJ; Hollingshead MG; Covey JM; Bigelow J; McCormack JJ; Buckheit RW; Clanton DJ; Turpin JA; Rice WG
J Med Chem; 1998 Jun; 41(13):2184-93. PubMed ID: 9632350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
